[Retracted] Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

Table 1

Comparison of clinical data between the two groups ().

Group	Number of patients	Sex		Age (years)		Duration of disease (years)		TNM staging
		Male	Female	Range	Mean	Range	Mean	Stage II	Stage III	Stage IV
Control group	42	26	16	42-75		2-8		20	16	6
Experimental group	42	27	15	40-74		2-8		19	15	8
	—	—	—	—	0.643	—	0.134	—	—	—
	—	—	—	—	0.522	—	0.894	—	—	—